Ian Davis, MD, PhD (IMAGE)

University of North Carolina Health Care

Ian Davis, MD, PhD

Caption

“Our approach revealed the identity of cells in a complex transplant mix, and this knowledge could help us develop novel therapeutic strategies,” said Ian Davis, MD, PhD. “We envision future therapies that, post-transplant, might direct a recovering immune system toward groups of immune cells associated with a favorable outcome.”

Credit

UNC Lineberger Comprehensive Cancer Center

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.